Nagayoshi, Y.; Nishiguchi, K.; Yamamura, R.; Chujo, T.; Oshiumi, H.; Nagata, H.; Kaneko, H.; Yamamoto, K.; Nakata, H.; Sakakida, K.;
et al. t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity. Biomolecules 2022, 12, 1233.
https://doi.org/10.3390/biom12091233
AMA Style
Nagayoshi Y, Nishiguchi K, Yamamura R, Chujo T, Oshiumi H, Nagata H, Kaneko H, Yamamoto K, Nakata H, Sakakida K,
et al. t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity. Biomolecules. 2022; 12(9):1233.
https://doi.org/10.3390/biom12091233
Chicago/Turabian Style
Nagayoshi, Yu, Kayo Nishiguchi, Ryosuke Yamamura, Takeshi Chujo, Hiroyuki Oshiumi, Hiroko Nagata, Hitomi Kaneko, Keiichi Yamamoto, Hirotomo Nakata, Korin Sakakida,
and et al. 2022. "t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity" Biomolecules 12, no. 9: 1233.
https://doi.org/10.3390/biom12091233
APA Style
Nagayoshi, Y., Nishiguchi, K., Yamamura, R., Chujo, T., Oshiumi, H., Nagata, H., Kaneko, H., Yamamoto, K., Nakata, H., Sakakida, K., Kunisawa, A., Adachi, M., Kakizoe, Y., Mizobe, T., Kuratsu, J.-i., Shimada, S., Nakamori, Y., Matsuoka, M., Mukoyama, M.,
... Tomizawa, K.
(2022). t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity. Biomolecules, 12(9), 1233.
https://doi.org/10.3390/biom12091233
